Aarti Asnani
Harvard University
H-index: 22
North America-United States
Top articles of Aarti Asnani
THE GLOBAL CARDIO-ONCOLOGY REGISTRY (G-COR) US PILOT STUDY: EARLY COHORT BREAST CANCER PATIENTS DEMOGRAPHICS AND EXERCISE HABITS
Journal of the American College of Cardiology
2024/4/2
Renal biomarkers in heart failure: systematic review and meta-analysis
2024/2/1
Assessing STEMI Outcomes in Patients With Cancer: A Call for Integrated Cardiovascular and Cancer Phenotyping
2024/1/9
Aarti Asnani
H-Index: 13
Inhibition of Cyp1a Protects Mice against Anthracycline Cardiomyopathy
bioRxiv
2024
Cardiomyocyte PGC-1α enables physiological adaptations to endurance exercise through suppression of GDF15 and cardiac atrophy
bioRxiv
2024
Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial
JAMA
2023/8/8
Abstract P3064: Cytotoxic T-cells Drive Doxorubicin Induced Cardiac Fibrosis And Systolic Dysfunction
Circulation Research
2023/8/4
Kuljeet Kaur
H-Index: 7
Aarti Asnani
H-Index: 13
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity
Cell metabolism
2023/6/6
New Insights Into Cardiac Wasting in Patients With Cancer
2023/4/25
Aarti Asnani
H-Index: 13
Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer
Cardio-Oncology
2023/4/5
Ashish Kumar
H-Index: 30
Amudha Kumar
H-Index: 3
David Martin
H-Index: 7
Aarti Asnani
H-Index: 13
Anju Nohria
H-Index: 30
Intermittent Fasting Potentiates Anthracycline Cardiotoxicity
Journal of Cardiac Failure
2023/4/1
CARDIOTOXICITY OF COMBINED PEGYLATED LIPOSOMAL DOXORUBICIN AND BEVACIZUMAB THERAPY
Journal of the American College of Cardiology
2023/3/7
Aarti Asnani
H-Index: 13
CLINICAL FEATURES AND OUTCOMES OF CARDIAC INVOLVEMENT IN PATIENTS WITH CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Journal of the American College of Cardiology
2023/3/7
The spatial ventricular gradient is an independent predictor of anthracycline-associated cardiotoxicity
JACC: Advances
2023/3/1
Gabriel Pajares Hurtado
H-Index: 1
Aarti Asnani
H-Index: 13
Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury
Basic to Translational Science
2023/3/1
Prolactin inhibition in peripartum cardiomyopathy: systematic review and meta-analysis
2023/2/1
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
2023/12/1
Aarti Asnani
H-Index: 13
Daniel Engelbertsen
H-Index: 12
Emilio Hirsch
H-Index: 45
Peter Van Der Meer
H-Index: 42
Pre-Existing Cardiovascular Disease Increases the Risk of Cardiovascular Adverse Events during Bruton Tyrosine Kinase Inhibitor Therapy
Blood
2023/11/28
Eunice Kim
H-Index: 13
Aarti Asnani
H-Index: 13
Sex Differences in the Development of Anthracycline-Associated Heart Failure
Journal of Cardiac Failure
2023/11/10
Gabriel Pajares Hurtado
H-Index: 1
Aarti Asnani
H-Index: 13
Cardiomyocyte PGC-1α Prevents Cardiac Atrophy and Failure in Response to Endurance Exercise Training
Circulation
2023/11/7